dyslipidemia - augusta universityand reducing dyslipidemia in children and adolescents. 2,4,5 the...

6
24 March 2011 • ADVANCE for NPs & PAs • www.advanceweb.com/NPPA CME/CE: Pediatrics CARDIoVASCulAR DISEASE (CVD) is the leading cause of morbidity and mortality in the United States. 1-3 Atherosclerosis begins in childhood and progresses through adulthood. 2,4,5 Among the main causes of atheroscle- rosis and CVD is abnormal cholesterol levels — particularly elevated low-density lipoprotein (LDL) cholesterol, increased triglycerides (TGs) and decreased high- density lipoprotein (HDL) cholesterol. 2,3,6 Because these processes begin early in life, it is important to correct abnormal lipid profiles during childhood to reduce the risk of subsequent negative outcomes such as CVD. 2 Healthcare providers must take special care to monitor risk factors in the U.S. pediatric population because of the ubiq- uity of unhealthy diets, decreased activity and increased rates of obesity, type 2 diabetes mellitus and metabolic syndrome in children. 2,3 Although a number of pharmacologic options are available and under development, lifestyle changes such as diet, weight loss and increased physical activity remain the cornerstones of treat- ing and preventing abnormal lipid levels in childhood. 2,3,7 This article reviews the specific nonpharmacologic recommenda- tions to prevent and treat dyslipidemia in the pediatric population. Expert Recommendations Because children grow rapidly from birth and progress through several develop- mental changes, childhood cholesterol levels can vary from year to year, 2 unlike the normal adult lipid profile. This pro- gression is important, because healthcare providers must take into account age and development when considering the pediatric lipid profile. 8 No correlation has been found between abnormal lipid levels in children younger than 2 years and future outcomes of dys- lipidemia in adolescence or adulthood. Therefore, assessing lipid profiles before 2 years old is not recommended. 2,9 In children older than 2 years, total cholesterol levels peak between ages 9 and 11, decrease during puberty and increase after puberty. 10 Because of these fluctuations, the American Academy of Pediatrics (AAP) has adopted multiple sets of guidelines for the assessment of lipid profiles in children. 2 The National Heart, Lung, and Blood Institute’s National Cholesterol Education Program (NCEP) guidelines use total cholesterol and LDL to classify children between 2 and 18 years into acceptable, borderline or elevated categories. 2,4 While the NCEP recommendations do not consider HDL and triglycer- ide categories, the American Heart Association (AHA) does recom- mend the inclusion of these two values in the evaluation of children; the AHA considers childhood HDL levels less than 35 mg/dL and TG levels greater than 150 mg/dL to be abnormal. 5 Table 1 outlines the NCEP and AHA categories. As a result of the age and developmental variability, the AAP also uses the Lipid Research Clinics Program Prevalence Study guidelines (Table 2) to adjust for learning objectives 1. Identify abnormal cholesterol levels in the pediatric population. 2. State the risk factors for dyslipidemia in the pediatric population. 3. Summarize the expert nonpharmacologic recommendations for preventing and treating dyslipidemia in the pediatric population. 4. Discuss the role of diet and exercise in children with dyslipidemia. JEFFREy LEESER/DORIS MOHR MAllOry e. McCOrD will graduate in May from the PA program at Georgia Health Sciences University in Augusta, Ga. lAUrA e. lee is an assistant professor and clinical director at the Georgia Health Sciences University PA program. They have completed a disclosure form and report no relationships related to the content of this article. The ADVANCE for NPs & PAs CME coordinator, John McGinnity, MS, PA-C, discloses receiving honoraria from Boehringer Ingelheim. by Mallory E. McCord, PA-S, and laura E. lee, MhE, PA-C Dyslipidemia In Children Nonpharmacologic approaches for early intervention

Upload: others

Post on 04-Oct-2020

1 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Dyslipidemia - Augusta Universityand reducing dyslipidemia in children and adolescents. 2,4,5 the Population Approach Maintenance of ideal body weight, an active lifestyle and appropriate

24 March 2011 • ADVANCE for NPs & PAs • www.advanceweb.com/NPPA

CME/CE: Pediatrics

➼ CARDIoVASCulAR DISEASE (CVD) is the leading cause of morbidity and mortality in the United States.1-3

Atherosclerosis begins in childhood and progresses through adulthood.2,4,5

Among the main causes of atheroscle-rosis and CVD is abnormal cholesterol levels — particularly elevated low-density lipoprotein (LDL) cholesterol, increased triglycerides (TGs) and decreased high-density lipoprotein (HDL) cholesterol.2,3,6

Because these processes begin early in life, it is important to correct abnormal lipid profiles during childhood to reduce the risk of subsequent negative outcomes such as CVD.2

Healthcare providers must take special care to monitor risk factors in the U.S. pediatric population because of the ubiq-uity of unhealthy diets, decreased activity and increased rates of obesity, type 2 diabetes mellitus and metabolic syndrome

in children.2,3 Although a number of pharmacologic options are available and under development, lifestyle changes such as diet, weight loss and increased physical activity remain the cornerstones of treat-ing and preventing abnormal lipid levels in childhood.2,3,7 This article reviews the specific nonpharmacologic recommenda-tions to prevent and treat dyslipidemia in the pediatric population.

Expert RecommendationsBecause children grow rapidly from birth and progress through several develop-mental changes, childhood cholesterol levels can vary from year to year,2 unlike the normal adult lipid profile. This pro-gression is important, because healthcare providers must take into account age and development when considering the pediatric lipid profile.8

No correlation has been found between abnormal lipid levels in children younger

than 2 years and future outcomes of dys-lipidemia in adolescence or adulthood. Therefore, assessing lipid profiles before 2 years old is not recommended.2,9

In children older than 2 years, total cholesterol levels peak between ages 9 and 11, decrease during puberty and increase after puberty.10 Because of these fluctuations, the American Academy of Pediatrics (AAP) has adopted multiple sets of guidelines for the assessment of lipid profiles in children.2 The National Heart, Lung, and Blood Institute’s National Cholesterol Education Program (NCEP) guidelines use total cholesterol and LDL to classify children between 2 and 18 years into acceptable, borderline or elevated categories.2,4

While the NCEP recommendations do not consider HDL and triglycer-ide categories, the American Heart Association (AHA) does recom-mend the inclusion of these two values in the evaluation of children; the AHA considers childhood HDL levels less than 35 mg/dL and TG levels greater than 150 mg/dL to be abnormal.5 Table 1 outlines the NCEP and AHA categories.

As a result of the age and developmental variability, the AAP also uses the Lipid Research Clinics Program Prevalence Study guidelines (Table 2) to adjust for

www.advanceweb.com/NPPA • ADVANCE for NPs & PAs • March 2011 25

learning objectives1. Identify abnormal cholesterol levels in the pediatric population.

2. State the risk factors for dyslipidemia in the pediatric population.

3. Summarize the expert nonpharmacologic recommendations for preventing and treating dyslipidemia in the pediatric population.

4. Discuss the role of diet and exercise in children with dyslipidemia.

JEFF

REy

LEES

ER/D

ORIS

MOH

R

MAllOry e. McCOrD will graduate in May from the PA program at Georgia Health Sciences University in Augusta, Ga. lAUrA e. lee is an assistant professor and clinical director at the Georgia Health Sciences University PA program. They have completed a disclosure form and report no relationships related to the content of this article. The ADVANCE for NPs & PAs CME coordinator, John McGinnity, MS, PA-C, discloses receiving honoraria from Boehringer Ingelheim.

by Mallory E. McCord, PA-S, and laura E. lee, MhE, PA-C

DyslipidemiaIn ChildrenNonpharmacologic approaches for early intervention

Page 2: Dyslipidemia - Augusta Universityand reducing dyslipidemia in children and adolescents. 2,4,5 the Population Approach Maintenance of ideal body weight, an active lifestyle and appropriate

www.advanceweb.com/NPPA • ADVANCE for NPs & PAs • March 2011 25

CME/CE: Pediatrics

lipid changes throughout childhood.2,9 According to these guidelines, concen-trations between the 90th and 95th per-centile should be considered borderline (between the 5th and 10th percentile for HDL levels), while concentrations above the 95th percentile (less than the 5th percentile for HDL levels) should be considered abnormal.2,9

two ApproachesThe AAP and the NCEP rec-

ommend two approaches for choosing which

c h i l d r e n t o

treat: the population approach and the individual approach.2,4,5 The population approach is a recommendation for all U.S. children and adolescents to help prevent CVD and to create a more desirable lipid profile for the entire population.2,4,5 The individual approach is a group of recom-mendations for high-risk children who are at the greatest risk for atherosclerosis, dys-lipidemia or CVD during youth or adult-hood.2,4,5 Unlike the recommendations in the population-based approach, these recommendations include more intensive treatments and possible pharmacologic interventions.2,4,5 The individual approach, however, recommends lifestyle changes as the initial therapy before pharmacologic intervention is indicated; therefore, both approaches focus on lifestyle change as the primary initial approach for preventing and reducing dyslipidemia in children and adolescents.2,4,5

the Population ApproachMaintenance of ideal body weight, an active lifestyle and appropriate eating patterns should be recommended to help prevent abnormal lipid levels and

cardiovascular disease.2,5 Following the population approach, a

Page 3: Dyslipidemia - Augusta Universityand reducing dyslipidemia in children and adolescents. 2,4,5 the Population Approach Maintenance of ideal body weight, an active lifestyle and appropriate

healthy diet plan should be recommended for all children and adolescents.5 It is important to note that the AHA, the NCEP and the AAP do not recommend dietary changes for any child younger than 2 years.2,4,5 The period from birth to 2 years is an important growth and development period that requires an increased intake of fats and nutrition; therefore, dietary interventions should be implemented only in toddlers at 2 or 3 years, as they are transitioning out of this growth period.2,4,5

For children older than 2 years, the first recommendation is to ensure that daily caloric intake matches energy needs and expenditure for adequate develop-ment and to maintain a healthy body weight.2,4,5,7 Children between 2 and 18 years should limit saturated fat con-sumption to less than 10% of total daily caloric intake, limit total fat to between 20% and 30% of total daily calories and limit cholesterol to less than 300 mg/day.2,4,5,7,11

A variety of foods should be con-sumed, including whole grains, fruits and vegetables (five or more a day), low-fat dairy products (1% or skim milk), high-fiber foods, legumes, lean meats and oily fish.2,5,6,11 Decreasing salt intake to less than 6 g per day and minimizing simple sugar consumption, including fruit juices and other foods and beverages with added sugars, also are recommended.2,4,5,7,11 Subsequent to increased attention on the lipid-profile–changing effects of trans fatty acids, such as hydrogenated and partially hydroge-nated fats, it is now recommended that trans fats be limited to less than 1% of total daily calories in children and ado-lescents.2,6,11,12

the Individual ApproachThe individual approach uses a two-step dietary intervention to treat children who have an abnormal lipid profile.2,4,5,7 The recommendations for the step 1 guidelines are for children with border-line LDL cholesterol levels (110–129 mg/dL).2,4,5,7 Step 1 guidelines are the same recommendations as those of the popula-tion approach; implementation of these dietary guidelines should be occur for 1 year before lipid profile reassessment.2,4,5,7 Step 2 guidelines are for children who either are in the borderline lipid profile category and have failed to reach goals after 3 months of step 1 therapy, or are in the abnormal LDL category (130 mg/dL or higher) and have completed 3 months of step 1 therapy.2,4,5,7

A dietitian should be consulted and included in the treatment process at this stage if one has not yet been involved.7 Step 2 guidelines include a diet with less than 7% of calories from saturated fat, less than 200 mg cholesterol per day and an increase in dietary fiber.5,7 Calculate recommended daily dietary fiber by taking the child’s age in years and add-ing 5 to 10 g per day; at age 15 through adulthood, a total of 25 to 35 g per day of fiber should be recommended.2,5 The additional step 1 recommendations should be continued through the step 2 phase of treatment.2,4,5,7

Questions About Diet RestrictionsConcerns about a restricted diet during pivotal growth periods in children have been countered by studies such as the Dietary Intervention Study in Children, which showed that reducing total fat, saturated fat and cholesterol in children did not result in statistically significant

changes in growth, overall nutritional sufficiency, iron stores, sexual matura-tion, mean BMI and psychological or social assessments.13 Other studies have shown that children in the active group of dietary intervention studies generally choose healthier food options than do children in the placebo group.2,13 Without proper guidance and education, however, children may not receive adequate nutri-tion, possibly leading to malnutrition, failure to thrive and inadequate growth or development.2,14 Further studies are necessary to ensure that these dietary interventions are not leading to unfa-vorable outcomes in later childhood or adulthood.14

A registered dietitian is a key player on the healthcare team when educating and instructing about dietary plans. This nutrition professional can help instruct parents and children on implement-ing dietary recommendations inside and outside of the home and making healthy choices.2 If a registered dietitian is unavailable, the primary care provider should fill this role and strive to provide nutritional education at each patient visit. It is essential to make dietary goals realistic and to incorporate the patient’s views and culture, as well as the family’s views, culture and circumstances, to help ensure that they can implement changes effectively.7

Exercise Is keyRegular physical activity is another impor-tant recommendation for children with dyslipidemia; assess activity time and level for every child at every visit.5 Regular physical activity in children can increase HDL levels, decrease TGs and improve LDL levels.2,15,16

26 March 2011 • ADVANCE for NPs & PAs • www.advanceweb.com/NPPA

CME/CE: Pediatrics

Table 1

lipid level Categories in ChildrenThe categories for lipid profile levels in pediatric populations as classified by the National Heart, Lung, and Blood Institute’s National Cholesterol Education Program and the American Heart Association.4,5

Category Total Cholesterol, mg/dl

low-Density lipoprotein

Cholesterol, mg/dl

high-Density lipoprotein

Cholesterol, mg/dl

Triglycerides, mg/dl

Acceptable < 170 < 110 ≥ 35 ≤ 150

borderline 170–199 110–129 — —

Elevated > 200 > 130 < 35 > 150

Page 4: Dyslipidemia - Augusta Universityand reducing dyslipidemia in children and adolescents. 2,4,5 the Population Approach Maintenance of ideal body weight, an active lifestyle and appropriate

The Centers for Disease Control and Prevention, the AHA and the AAP rec-ommend that children and adolescents older than 2 years should engage in at least 60 minutes of daily moderate to vigorous physical activity.5,15-18 This time recommendation can be continuous or can be broken into increments.17

Physical activity should include a vari-ety of activities that are enjoyable to the child, that support his or her devel-opmental stage and that are a mix of structured and unstructured activities.5,7,19 Age-appropriate activities can include a group or can be individual, and they can range from walking and running to group sports to household chores.17

In children and adolescents 10 years and older, resistance training that uses low weights and high repetitions can be incorporated into daily physical activity if proper technique is followed and proper supervision is available.17 Heavy weights

and lifts with maximum weight can be added when an adolescent has reached Tanner stage 5, given that proper tech-nique is still a focus.17,19

For children who are not meeting the recommended 60 minutes of daily physical activity, a gradual introduction of activity by weekly or monthly increments might help reduce injury risk and prevent a return to inactivity.16 No particular activity recommendations exist to cor-relate with specified lipid profile ranges; physical activity should be recommended to all children, and sedentary behaviors should be discouraged, especially for children with dyslipidemia.

Health experts generally recommend that sedentary activities such as watch-ing TV, playing video games and using a computer should be limited to less than 2 hours a day. The AAP recommends that children younger than 2 years be restricted from watching any TV.20

other InterventionsOther important nonpharmacologic rec-ommendations are weight management and avoidance of smoking tobacco.2,5 The primary treatment for any overweight or obese child with dyslipidemia should be weight management and reduction, which should involve dietary changes and increased physical activity.2,5 The goal is to maintain a healthy BMI that is below the 95th percentile.5

Avoidance of smoking and smoke exposure also is necessary to maintain a healthy lipid profile; preventing personal smoking or secondhand smoke exposure should be a primary goal for children with dyslipidemia.5 Question family members and caregivers about smoking history at every visit; questioning children about personal smoking history should begin at age 10.5 Provide counseling and resources, if necessary, to decrease all routes of smoke exposure.5

www.advanceweb.com/NPPA • ADVANCE for NPs & PAs • March 2011 27

CME/CE: Pediatrics

Table 2

lipid Profile Distribution in ChildrenLipid profile distribution prevalence for the pediatric population according to Lipid Research Clinics Program Prevalence Study guidelines.9

CategoryMales Females

5–9 y 10–14 y 15–19 y 5–9 y 10–14 y 15–19 y

total cholesterol, mg/dl

50th percentile 153 161 152 164 159 157

75th percentile 168 173 168 177 171 176

90th percentile Borderline 183 191 183 189 191 198

≥ 95th percentile Abnormal 186 201 191 197 205 208

triglycerides, mg/dl

50th percentile 48 58 68 57 68 64

75th percentile 58 74 88 74 85 85

90th percentile Borderline 70 94 125 103 104 112

≥ 95th percentile Abnormal 85 111 143 120 120 126

low-density lipoprotein cholesterol, mg/dl

50th percentile 90 94 93 98 94 93

75th percentile 103 109 109 115 110 110

90th percentile Borderline 117 123 123 125 126 129

≥ 95th percentile Abnormal 129 133 130 140 136 137

high-density lipoprotein cholesterol, mg/dl

≤ 5th percentile Abnormal 38 37 30 36 37 35

10th percentile Borderline 43 40 34 38 40 38

25th percentile 49 46 39 48 45 43

50th percentile 55 55 46 52 52 51

Page 5: Dyslipidemia - Augusta Universityand reducing dyslipidemia in children and adolescents. 2,4,5 the Population Approach Maintenance of ideal body weight, an active lifestyle and appropriate

28 March 2011 • ADVANCE for NPs & PAs • www.advanceweb.com/NPPA

CME/CE: Pediatrics

If nonpharmacologic interventions do not help to achieve lipid profile goals, children older than 8 years with an LDL level greater than 190 mg/dL, an LDL level of 160 mg/dL or greater with other cardiovascular risks present (hyperten-sion, obesity, family history of CVD), or an LDL level of 130 mg/dL or greater with diabetes mellitus present should be con-sidered for pharmacologic therapy.2,5,21

Research is under way to study the effectiveness and safety of using lip-id-lowering therapies in children. Nonpharmacologic recommendations, however, always should be first-line ther-apy and should be continued throughout the course of pharmacotherapy.21

Treating children with dyslipidemia should be a cooperative effort among the child and his or her healthcare provider, caregivers and family members, and other key figures such as dietitians and school personnel. Involving caregivers may help children who depend on them gain better access to physical activity and healthier sources of food and may provide an additional source of encouragement through treatment.3

A school system can help implement changes in the school environment dur-ing mealtimes, in health and physical education curriculums and in the general classroom.3

Setting realistic expectations, properly

educating all parties involved and deeply investing time into each pediatric patient can help him or her reach cholesterol level goals and decrease the risk of future CVD. ■

References1. Lloyd-Jones D, et al. Heart disease and stroke sta-

tistics—2010 update: a report from the American Heart Association. Circulation. 2010;121(7):e46-e215.

2. Daniels SR, et al. Lipid screening and cardiovas-cular health in childhood. Pediatrics. 2008;122(1):198-208.

3. Gidding SS, et al. Implementing American Heart Association pediatric and adult nutrition guidelines: a scientific statement from the American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular Disease in the Young, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council for High Blood Pressure Research. Circulation. 2009;119(8):1161-1175.

4. American Academy of Pediatrics. National Cholesterol Education Program: report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics. 1992;89(3 pt 2):525-584.

5. Kavey RE, et al. American Heart Association guidelines for primary prevention of atherosclerotic cardiovascular disease beginning in childhood. J Pediatr. 2003;142(4):368-372.

6. Lichtenstein AH, et al. Diet and lifestyle recom-mendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation. 2006;114(1):82-96.

7. Williams CL, et al. Cardiovascular health in childhood: a statement for health professionals from the Committee on Atherosclerosis, Hypertension, and Obesity in the Young (AHOY) of the Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2002;106(1):143-160.

8. Friedman LA, et al. Sensitivity and specificity of pediatric lipid determinations for adult lipid status: findings from the Princeton Lipid Research Clinics Prevalence Program Follow-up Study. Pediatrics. 2006;118(1):165-172.

9. Tamir I, et al. Lipid and lipoprotein distributions in white children ages 6-19 yr: the Lipid Research

Clinics Program Prevalence Study. J Chronic Dis. 1981;34(1):27-39.

10. Hickman TB, et al. Distributions and trends of serum lipid levels among United States children and adolescents ages 4-19 years: data from the Third National Health and Nutrition Examination Survey. Prev Med. 1998;27(6):879-890.

11. Gidding SS, et al. Dietary recommendations for children and adolescents: a guide for practitioners: con-sensus statement from the American Heart Association. Circulation. 2005;112(13):2061-2075.

12. Woodside JV, et al. Saturated and trans fatty acids and coronary heart disease. Curr Atheroscler Rep. 2008;10(6):460-466.

13. Writing Group for the DISC Collaborative Research Group. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol: the Dietary Intervention Study in Children (DISC). JAMA. 1995;273(18):1429-1435.

14. Lifshitz F, Tarim O. Considerations about dietary fat restrictions for children. J Nutr. 1996;126(4 suppl):1031S-1041S.

15. Maron BJ, et al. Recommendations for physi-cal activity and recreational sports participation for young patients with genetic cardiovascular diseases. Circulation. 2004;109(22):2807-2816.

16. Strong WB, et al. Evidence based physical activity for school-age youth. J Pediatr. 2005;146(6):732-737.

17. Council on Sports Medicine and Fitness, Council on School Health. Active healthy living: prevention of childhood obesity through increased physical activity. Pediatrics. 2006;117(5):1834-1842.

18. Physical activity for everyone: how much physical activity do children need? Centers for Disease Control and Prevention Web site. http://www.cdc.gov/physica-lactivity/everyone/guidelines/children.html. Updated May 10, 2010. Accessed Jan. 28, 2011.

19. Joy EA. Practical approaches to office-based physi-cal activity promotion for children and adolescents. Curr Sports Med Rep. 2008;7(6):367-372.

20. American Academy of Pediatrics Committee on Public Education. Children, adolescents, and television. Pediatrics. 2001;107(2):423-426.

21. McCrindle BW, et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scien-tific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation. 2007;115(14):1948-1967.

Table 3

Clinical Recommendations for Dyslipidemia in Children2,4-9,11

Population Approach Individual Approach

Dietary changes No change for < 2 years old; > 2 years old, match daily caloric intake to energy needs and expenditure

Two-step dietary intervention for children with abnormal lipid profile

Fat consumption (% total caloric intake)

Ages 2 to 18:• Saturated fat consumption < 10% of total daily caloric

intake• Total fat between 20–30% of total daily caloric intake• Cholesterol < 300 mg/day• Limit trans fats to < 1% of total daily caloric intake

Step 1, for children with borderline LDL cholesterol readings (110–129 mg/dL): Same as population approach for 1 yearStep 2, for children with borderline lipid profile who do not reach goal after 3 months of step 1 therapy, or LDL > 130 mg/dL after 3 months of step 1 therapy:• Saturated fat consumption < 7% of total daily caloric intake• Cholesterol < 200 mg/day

other measures • Eat a variety of foods, especially whole grains, fruits and vegetables (5 or more a day), low-fat dairy products (1% or skim milk), high-fiber foods, legumes, lean meats and oily fish

• Decrease salt intake to < 6 g per day• Minimize simple sugar consumption

Increase dietary fiber, calculated by taking the child’s age in years and adding 5–10 g/day; at ages 15 through adult, 25–35 g/day of fiber

Page 6: Dyslipidemia - Augusta Universityand reducing dyslipidemia in children and adolescents. 2,4,5 the Population Approach Maintenance of ideal body weight, an active lifestyle and appropriate

www.advanceweb.com/NPPA • ADVANCE for NPs & PAs • March 2011 29

CME/CE: Pediatrics

Registrant Information (Please Print)

Subscriber No. (see mailing label) ____ ____ ____ ____ ____ ____ ____ ____ ____

Required for Florida NPs: License No. ___________________________________________

E-mail Address ______________________________________________________________

Name ______________________________________________________________________

Address ❏ Work ❏ Home ___________________________________________________

City ____________________________________ State ______ Zip Code _______________

Phone No. ❏ Work ❏ Home _________________________________________________

Payment: $10❏ For PAs: Check Payable to Wayne State University

❏ For NPs: Check Payable to Merion Matters

❏ For PAs or NPs: Credit Card No. ________________________ Exp. Date___________

Cardholder Name ________________________________________________________

Signature _______________________________________________________________

❏ American Express ❏ Visa ❏ MasterCard ❏ Discover

Statement of CompletionI attest to having completed the CME/CE activity.

Signature _____________________________________________ Date _________________

Profession ❏ Nurse Practitioner ❏ Physician Assistant

Questions1. Which one of the following is not an abnormal cholesterol level?a. elevated low-density lipoprotein cholesterolb. increased triglyceridesc. decreased triglyceridesd. decreased high-density lipoprotein

2. Which of the following is true of total cholesterol levels in children older than 2 years?a. They peak between 9 and 11 years, decrease during puberty and increase after puberty.b. They peak between 2 and 4 years, decrease during puberty and increase after puberty.c. They peak during puberty and decrease after puberty.d. They increase during puberty and decrease after puberty.

3. the National heart, lung, and blood Institute’s National Choles-terol Education Program guide-lines use which of the following to classify children between 2 and 18 years into acceptable, border-line or elevated categories?a. total cholesterol and HDLb. total cholesterol and triglyceridesc. total cholesterol and LDLd. triglycerides and LDL

4. While the NCEP recommenda-tions do not consider hDl and trig-lyceride categories, the American heart Association does recommend the inclusion of these values in the evaluation of pediatric populations.a. true b. false

5. In the population approach to treating pediatric dyslipidemia, children between 2 and 18 years should do which of the following?a. limit saturated fat consumption to less than 10% of total daily caloric intakeb. limit total fat to between 20% and 30% of total daily caloriesc. limit cholesterol to less than 300 mg/dayd. all of the above

6. In the population approach to treating pediatric dyslipidemia, it is now recommended that trans fats be limited to what percentage of total daily calories in children and adolescents?a. less than 10% b. less than 5%c. less than 3% d. less than 1%

7. In the individual approach to treating pediatric dyslipidemia, which one of the following is not among the step 2 guidelines?a. a diet with less than 7% of calories from saturated fatb. less than 200 mg cholesterol per dayc. pharmacologic interventiond. an increase in dietary fiber8. the Dietary Intervention

Study in Children showed that reducing total fat, saturated fat and cholesterol in children did not result in statistically significant changes in growth, overall nutritional sufficiency, iron stores, sexual maturation, mean bMI and psychological or social assessments.a. true b. false

9. Expert groups recommend that children and adolescents older than 2 years should engage in how much daily moderate to vigorous physical activity?a. at least 30 minutesb. at least 45 minutesc. at least 60 minutesd. at least 90 minutes

10. If nonpharmacologic interven-tions do not help to achieve lipid profile goals, children older than 8 years should be considered for pharmacologic therapy under which of the following scenarios?a. they have an LDL level greater than 190 mg/dLb. they have an LDL level of 160 mg/dL or greater with other cardiovascular risks presentc. they have an LDL level of 130 mg/dL or greater with diabetes mellitus presentd. all of the above

Evaluation1. the content was appropriate for my needs.a. strongly disagreeb. disagreec. neutrald. agreee. strongly agree

2. the educational objectives were achieved.a. strongly disagreeb. disagreec. neutrald. agreee. strongly agree

3. the information provided was practical and can be applied to my professional needs.a. strongly disagreeb. disagreec. neutrald. agreee. strongly agree

4. the information in the article was fair, balanced, free of commercial bias and supported by scientific evidence.a. strongly disagreeb. disagreec. neutrald. agreee. strongly agree

Dyslipidemia in Children • NPPA07

Registration & Answer FormThis activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Wayne State University School of Medicine and ADVANCE for NPs & PAs. The Wayne State University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

The Wayne State University School of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s).™ Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity also is approved for 2 CE contact hours. The issuer of CE contact hours is Merion Publications (a division of Merion Matters), which is approved as a provider of continuing education in nursing by three agencies. For details on CE provider numbers, visit the CE Test Center on our website, www.advanceweb.com/NPPA.

For PAs:to obtain CME credit, send the completed answer form and registrant information to Wayne State University School of Medicine, Attn PA, University Health Center 9A, 4201 Saint Antoine St., Detroit, MI 48201. Include a check for $10 payable to Wayne State University. Or fax the completed form and credit card information to (313) 577-7554. For online payment, visit http://www.med.wayne.edu/cme/calendarReg.html. Test takers who earn a passing score will receive a CME certificate by mail, or if paying online can receive an online transcript once registered at http://www.med.wayne.edu/cme/calendarTran.html. For questions about CME, call Wayne State University at (313) 577-1453. This CME form must be postmarked or received within 6 months of the last day of the month of this issue of ADVANCE.

For NPs:to obtain CE contact hours, take this test online at www.advanceweb.com/NPPA and receive instant test results and a printable CE certificate upon passage. Or fax the completed form and credit card information to (610) 278-1426. Or send the completed answer form and registrant information to Merion Matters CE Program for NPs, 2900 Horizon Dr., King of Prussia, PA 19406. Include a check for $10 payable to Merion Matters. This activity is eligible for CE credit for 2 calendar years after publication.

test NPPA07 A b C D

1.

2.

3.

4.

5.

A b C D

6.

7.

8.

9.

10.

Evaluation A b C D E

1.

2.

3.

4.

Dyslipidemia in Children March 2011